Evidence map›Paper›PMID 42400534›Full record

ArticleLangmuir : the ACS journal of surfaces and colloids2026

Design and Characterization of Hybrid Glucose-Powered Enzymatic Biofuel Cells Based on the Combination of Different Gold-Based Nanocompounds.

Natalija German, Almira Ramanaviciene, Arunas Ramanavicius

Abstract read
In one paragraph

Article in Langmuir : the ACS journal of surfaces and colloids, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Natalija GermanDepartment of Immunology and Bioelectrochemistry, State Research Institute Centre for Innovative Medicine, Santariskiu 5, LT-08406 Vilnius, Lithuania.
Almira RamanavicieneDepartment of Immunology and Bioelectrochemistry, State Research Institute Centre for Innovative Medicine, Santariskiu 5, LT-08406 Vilnius, Lithuania.ORCID 0000-0001-5864-0359
Arunas RamanaviciusNanoTechnas - Center of Nanotechnology and Materials Science, Faculty of Chemistry and Geosciences, Vilnius University, LT-03225 Vilnius, Lithuania.ORCID 0000-0002-0885-3556

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study highlights the development of 5 different membraneless glucose enzymatic biofuel cells, which are capable of operating in dual modes (biofuel cells and sensors). In these biofuel cells, different bioanodes were used, consisting of graphite rods (GRs) modified with gold nanoparticles (AuNPs), dendritic gold nanostructures (DAuNSs), or both types of above-mentioned nanostructures covered by cystamine (Cys), a redox mediator (1,10-phenathroline-5,6-dione (PD)), and differently immobilized glucose oxidase (GOx). The Cys-based self-assembled monolayer (SAM) provided a platform for covalent GOx immobilization on the surface of the above-mentioned gold-based structures. A single-compartment-based membraneless design was applied for all three here designed hybrid enzymatic biofuel cells (G-EBFCs), which were all powered by glucose. Electrically conducting nanocompounds served as support for immobilization, while PD served as a redox mediator to enhance the current of G-EBFCs. The electrochemical behavior of the fabricated bioanodes, assessed by G-EBFCs, was investigated by cyclic voltammetry (CV) and direct voltage measurements. Although both GR/Cys/AuNPs/PD/GOx and GR/AuNPs/Cys/PD/GOx bioanodes were characterized by rather high power density, surface concentration of GOx, sensitivity, and low limit of detection, the GR/AuNPs/Cys/PD/GOx bioanode was considered more suitable for glucose biosensing in real samples due to its long-term stability and excellent anti-interference capability. The technological challenges discussed in this study open new horizons for simpler and more cost-effective designs of hybrid G-EBFCs and glucose biosensors, suitable for biomedical applications and the monitoring of beverage quality.

Indexed as

Bioelectric Energy SourcesGlucoseGlucose OxidaseGoldMetal NanoparticlesElectrodesEnzymes, ImmobilizedEnzymes, ImmobilizedGlucoseGlucose OxidaseGold

Identifiers

PMID42400534
PMCPMC13394398

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.